CA2388432A1 - Modification post-traductionnelle de proteines de recombinaison produites dans les plantes - Google Patents

Modification post-traductionnelle de proteines de recombinaison produites dans les plantes Download PDF

Info

Publication number
CA2388432A1
CA2388432A1 CA002388432A CA2388432A CA2388432A1 CA 2388432 A1 CA2388432 A1 CA 2388432A1 CA 002388432 A CA002388432 A CA 002388432A CA 2388432 A CA2388432 A CA 2388432A CA 2388432 A1 CA2388432 A1 CA 2388432A1
Authority
CA
Canada
Prior art keywords
plant
host system
post
plant host
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388432A
Other languages
English (en)
Inventor
Douglas Russell
Siva Manjunath
Ronald Bassuner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Technology LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388432A1 publication Critical patent/CA2388432A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un procédé relatif à la production de protéines ou de polypeptides par le biais de plantes ou cellules de plantes manipulées génétiquement, ainsi que des plantes ou cellules de plantes manipulées génétiquement proprement dites (y compris les parties de ces plantes manipulées), le matériau de protéine hétérologue (par exemple, protéine, polypeptide et autre) que l'on produit à l'aide desdites plantes ou cellules de plantes manipulées, et enfin les polynucléotides de recombinaison (ADN ou ARN) utilisés pour la manipulation génétique.
CA002388432A 1999-10-21 2000-10-20 Modification post-traductionnelle de proteines de recombinaison produites dans les plantes Abandoned CA2388432A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16075899P 1999-10-21 1999-10-21
US60/160,758 1999-10-21
US19528200P 2000-04-07 2000-04-07
US60/195,282 2000-04-07
PCT/US2000/029027 WO2001029242A2 (fr) 1999-10-21 2000-10-20 Modification post-traductionnelle de proteines de recombinaison produites dans les plantes

Publications (1)

Publication Number Publication Date
CA2388432A1 true CA2388432A1 (fr) 2001-04-26

Family

ID=26857200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388432A Abandoned CA2388432A1 (fr) 1999-10-21 2000-10-20 Modification post-traductionnelle de proteines de recombinaison produites dans les plantes

Country Status (5)

Country Link
EP (1) EP1224309A2 (fr)
AU (1) AU1573601A (fr)
BR (1) BR0014945A (fr)
CA (1) CA2388432A1 (fr)
WO (1) WO2001029242A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020176972A1 (fr) * 2019-03-06 2020-09-10 Plantform Corporation Vecteurs d'adn-t ayant des séquences 5' modifiées en amont d'enzymes de modification post-traductionnelles et leurs procédés d'utilisation

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6998267B1 (en) 1998-12-09 2006-02-14 The Dow Chemical Company Method for manufacturing glycoproteins having human-type glycosylation
PT1772518E (pt) * 1999-10-26 2010-10-28 Stichting Dienst Landbouwkundi Glicosilação do tipo mamífero em plantas
AT409381B (de) * 2000-03-03 2002-07-25 Gloessl Josef Dr Xylosyltransferase-gen
AU2001266557A1 (en) 2000-04-12 2001-10-23 Human Genome Sciences, Inc. Albumin fusion proteins
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7632983B2 (en) 2000-07-31 2009-12-15 Biolex Therapeutics, Inc. Expression of monoclonal antibodies in duckweed
JP2005505234A (ja) 2001-01-19 2005-02-24 ザ　ダウ　ケミカル　カンパニー 植物細胞によるヒト型糖鎖をもつ糖タンパク質の分泌生産方法
EP1399572A4 (fr) * 2001-06-05 2005-02-09 Karen K Oishi Expression genique et production de proteines tgf-b comprenant une substance inhibitrice mullerienne bioactive issue de vegetaux
EP1404851A4 (fr) * 2001-06-08 2005-05-25 Icon Genetics Inc Production de proteines vegetales
EP2990417A1 (fr) 2001-12-21 2016-03-02 Human Genome Sciences, Inc. Protéines de fusion d'albumine et insuline
CN101613705A (zh) * 2002-03-19 2009-12-30 国际植物研究所 在植物中优化聚糖生成
AU2008202355B2 (en) * 2002-03-19 2011-04-07 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
NZ534881A (en) 2002-03-19 2006-09-29 Plant Res Internat B Mammalian GnTIII expression in plants
CL2003002461A1 (es) 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
AU2003294912B2 (en) * 2002-12-20 2009-06-04 Greenovation Biotech Gmbh Production of heterologous glycosylated proteins in bryophyte cells
PT1431394E (pt) * 2002-12-20 2006-12-29 Greenovation Biotech Gmbh Metodo de produção de proteinas glicosiladas heterologas em celulas de briofitos
WO2004067029A1 (fr) * 2002-12-27 2004-08-12 Shenzhen Tsinghua Yuanxing Bio-Pharm Science & Technology Co., Ltd. Procede de preparation d'un vaccin et vaccins antitumoraux
PL222221B1 (pl) * 2003-01-22 2016-07-29 Glycart Biotechnology Ag Sposób wytwarzania polipeptydu w komórce gospodarza
CN100427599C (zh) * 2003-12-26 2008-10-22 吉林大学第一医院 Albsin/il－18mat杂交细胞因子
EP3088528B1 (fr) * 2004-09-29 2019-07-03 Collplant Ltd. Plantes produisant du collagene et procedes de generation et d'utilisation de celles-ci
US8455717B2 (en) 2004-09-29 2013-06-04 Collplant Ltd. Collagen producing plants and methods of generating and using same
WO2007084922A2 (fr) 2006-01-17 2007-07-26 Biolex Therapeutics, Inc. Compositions et procédés d'humanisation et optimisation de n-glycanes chez les plantes
EP1816201A1 (fr) 2006-02-06 2007-08-08 CSL Behring GmbH Facteur de coagulation VIIa modifié ayant une stabilité 'half-life' améliorée
JP5568702B2 (ja) * 2006-11-08 2014-08-13 サントル ナショナル ドゥ ラ ルシェルシュ スィヤンティフィック（セーエヌエルエス） 組換えポリペプチドの発現および翻訳後修飾の制御を標的化するための配列を有するポリペプチド
WO2008125972A2 (fr) 2007-04-17 2008-10-23 Plant Research International B.V. Glycosylation de type mammifère dans des plantes par l'expression de glycosyltransférases non mammifères
NZ598417A (en) * 2007-06-15 2013-06-28 Centre Nat Rech Scient Modifying glycoprotein production in plants
EP2205728A1 (fr) * 2007-10-31 2010-07-14 Bayer BioScience N.V. Procédé de production de plantes modifiées à schéma de n-glycosylation modifié
ES2883176T3 (es) 2007-11-08 2021-12-07 Prec Biologics Inc Anticuerpos monoclonales recombinantes y antígenos correspondientes para cánceres de colon y de páncreas
MX370690B (es) 2008-07-18 2019-12-19 Medicago Inc Epitopo de inmunizacion de nuevo virus de la influenza.
EP2773964A4 (fr) * 2011-11-03 2015-06-24 Stc Biolog Inc Procédé de détermination de propriétés pharmacologiques de protéines recombinantes
WO2014130922A1 (fr) 2013-02-25 2014-08-28 Trustees Of Boston University Compositions et procédés pour le traitement d'infections fongiques
GB201308120D0 (en) 2013-05-06 2013-06-12 Baden Wuerttemberg Stiftung Gmbh Recombinant protein and method for its production
CN105517572B (zh) 2013-07-05 2019-05-31 华盛顿大学商业中心 用于治疗癌症的中和可溶性mic的单克隆抗体
JPWO2015050005A1 (ja) * 2013-10-02 2017-03-09 株式会社ＵｎｉＢｉｏ Ｅｇｆ受容体を介して細胞増殖を促進するタンパク質組成物
BR112017010555A2 (pt) 2014-11-20 2018-02-27 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd composições e métodos para produção de polipeptídeos com padrão de glicosilação modificado em células vegetais
MA44873A (fr) 2016-04-15 2019-03-13 Univ Pennsylvania Composition pour le traitement de la dégénérescence maculaire liée a l'âge exsudative
SG11201808440YA (en) * 2016-04-15 2018-10-30 Regenxbio Inc Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
CA3184940A1 (fr) 2020-07-07 2022-01-13 Jennifer Donglan WU Anticorps mic et agents de liaison et leurs procedes d'utilisation
CA3209479A1 (fr) 2021-02-03 2022-08-11 Mozart Therapeutics, Inc. Agents de liaison et leurs methodes d'utilisation
AU2022253902A1 (en) 2021-04-10 2023-11-02 Profoundbio Us Co. Folr1 binding agents, conjugates thereof and methods of using the same
TW202308699A (zh) 2021-04-23 2023-03-01 美商普方生物製藥美國公司 Ｃｄ７０結合劑、其結合物及其使用方法
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法
AU2022310688A1 (en) 2021-07-13 2024-01-18 Keystone Bio, Inc. Diagnostics for porphyromonas gingivalis
WO2023076876A1 (fr) 2021-10-26 2023-05-04 Mozart Therapeutics, Inc. Modulation de réponses immunitaires à des vecteurs viraux
CA3238167A1 (fr) 2021-11-19 2023-05-25 Maria Leia Smith Agents de liaison de gpc3, leurs conjugues et leurs procedes d'utilisation
WO2024030956A2 (fr) 2022-08-03 2024-02-08 Mozart Therapeutics, Inc. Agents de liaison se liant spécifiquement à cd39 et leurs méthodes d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors
DE19754622A1 (de) * 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
US6998267B1 (en) * 1998-12-09 2006-02-14 The Dow Chemical Company Method for manufacturing glycoproteins having human-type glycosylation
PT1772518E (pt) * 1999-10-26 2010-10-28 Stichting Dienst Landbouwkundi Glicosilação do tipo mamífero em plantas
WO2001031044A1 (fr) * 1999-10-26 2001-05-03 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Gonadotrophines dans les plantes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020176972A1 (fr) * 2019-03-06 2020-09-10 Plantform Corporation Vecteurs d'adn-t ayant des séquences 5' modifiées en amont d'enzymes de modification post-traductionnelles et leurs procédés d'utilisation
EP3935180A4 (fr) * 2019-03-06 2022-12-28 Plantform Corporation Vecteurs d'adn-t ayant des séquences 5' modifiées en amont d'enzymes de modification post-traductionnelles et leurs procédés d'utilisation

Also Published As

Publication number Publication date
AU1573601A (en) 2001-04-30
BR0014945A (pt) 2004-08-31
WO2001029242A2 (fr) 2001-04-26
WO2001029242A3 (fr) 2002-02-21
EP1224309A2 (fr) 2002-07-24

Similar Documents

Publication Publication Date Title
CA2388432A1 (fr) Modification post-traductionnelle de proteines de recombinaison produites dans les plantes
CN100532558C (zh) 在植物中优化聚糖生成
US8058512B2 (en) Gene expression and production of TGF-β proteins including bioactive mullerian inhibiting substance from plants
AU760394B2 (en) Vegetable (GntI) sequences and the use thereof to obtain plants with a reduced or lack of N-acetylglucosaminyltransferase I (GnTI) activity
EP2147108B1 (fr) Glycolisation de type mammifère dans les plantes par l'expression de glycosyl-transférases des non-mammifères
US20030167531A1 (en) Expression and purification of bioactive, authentic polypeptides from plants
CA2549932A1 (fr) Ameliorations apportees ou associees a la production de proteines
AU2012202479B2 (en) Optimizing glycan processing in plants
US20110047657A1 (en) Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
AU2013205260B2 (en) Optimizing glycan processing in plants
AU2008202355B2 (en) Optimizing glycan processing in plants
AU2016203395A1 (en) Optimizing glycan processing in plants
AU2002312328A1 (en) Gene expression and production of TGF-B proteins including bioactive mullerian inhibiting substance from plants

Legal Events

Date Code Title Description
FZDE Discontinued